DAVID BROWN, M.D.
Ophthalmology Physician · HOUSTON, TX
Individual Active NPI 1548368509
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 964 | 37,989 | $23,627,845 | $7,407,084 | $5,871,583 |
| 2023 | 1,039 | 19,980 | $22,668,460 | $7,291,016 | $5,772,264 |
| 2022 | 1,158 | 17,140 | $11,922,694 | $5,921,840 | $4,671,468 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 13,275 | $147 | $117 |
| J0177 | Injection, aflibercept hd, 1 mg | 7,160 | $330 | $263 |
| 92134 | Imaging of retina | 2,639 | $42 | $32 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 2,184 | $225 | $179 |
| 67028 | Injection of drug into eye | 1,934 | $147 | $113 |
| 92014 | Established patient complete exam of visual system | 1,288 | $130 | $94 |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 980 | $166 | $132 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 900 | $109 | $86 |
| J0178 | Injection, aflibercept, 1 mg | 796 | $816 | $649 |
| J3590 | Unclassified biologics | 311 | $2,659 | $2,114 |
| J2778 | Injection, ranibizumab, 0.1 mg | 220 | $137 | $109 |
| 92250 | Photography of the retina | 91 | $38 | $29 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | H5425 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | H5425 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1295817609
- NPI 1023436896
- NPI 1588815468
- NPI 1437254976
- NPI 1477290617
- NPI 1619491941
- NPI 1336405463
- NPI 1811519358
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.